Prospects for China’s Pharmaceutical Industry Development During the 15th Five-Year Plan Period

Huili CAO, Boyang LI, Guoxu WEI

Acta Academiae Medicinae Sinicae ›› 2026, Vol. 48 ›› Issue (3) : 393-397.

PDF(804 KB)
Home Journals Acta Academiae Medicinae Sinicae
Acta Academiae Medicinae Sinicae

Abbreviation (ISO4): Acta Academiae Medicinae Sinicae      Editor in chief: Xuetao CAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(804 KB)
Acta Academiae Medicinae Sinicae ›› 2026, Vol. 48 ›› Issue (3) : 393-397. DOI: 10.3881/j.issn.1000-503X.17440
Health Policy & Industrial Development

Prospects for China’s Pharmaceutical Industry Development During the 15th Five-Year Plan Period

Author information +
History +

Abstract

The pharmaceutical industry is a strategic sector bearing on national economy,development,and security.It represents one of the fields featuring highly active scientific innovation,fierce international competition,and high policy attention.Amidst profound adjustments in the global pharmaceutical landscape and the deep advancement of a new round of scientific and technological revolution and industrial transformation,the 15th Five-Year Plan period marks a critical stage for China’s pharmaceutical industry to achieve high-quality development.This article systematically analyzes the characteristics and strategic positioning of the pharmaceutical industry,reviews the development landscape and trends of the global pharmaceutical industry,and objectively summarizes China’s current status of this industry in terms of industrial scale,innovation capability,industrial clustering,and internationalization.The study suggests that during the 15th Five-Year Plan period,China’s pharmaceutical industry faces five major new situations—new strategic positioning,new market demands,emerging technologies,fresh growth drivers,and a reshaped industrial landscape,with opportunities outweighing challenges.To achieve high-quality development during the 15th Five-Year Plan period,the industry should adhere to five principles:prioritizing scale-driven expansion to enlarge industrial footprint,boosting technological foundation to anchor innovation-led development,advancing business model innovation to foster new application scenarios,adhering to people-centered development to ramp up high-quality product supply,and optimizing the industrial ecosystem to refine supporting guarantee systems.

Key words

pharmaceutical industry / biomedical industry / the 15th Five-Year Plan period / emerging pillar industry / innovation / prospect

Cite this article

Download Citations
Huili CAO , Boyang LI , Guoxu WEI. Prospects for China’s Pharmaceutical Industry Development During the 15th Five-Year Plan Period[J]. Acta Academiae Medicinae Sinicae. 2026, 48(3): 393-397 https://doi.org/10.3881/j.issn.1000-503X.17440

References

[1]
IMS Health. IMS Health forecasts global pharmaceutical market growth of 5-7 percent in 2011,reaching $880 billion[R]. Norwalk: IMS Health, 2010.
[2]
IQVIA. IQVIA early bird:2025 revealed-the trends shaping pharma’s future[EB/OL].(2026-03-11)[2026-06-09]. https://www.iqvia.com/blogs/2026/03/iqvia-early-bird-2025-revealed.
[3]
IQVIA. Global medicine spending and usage trends outlook to 2026[R]. Durham: IQVIA Institute for Human Data Science, 2022.
[4]
IFPMA,WifOR Institute. The economic impact of the global pharmaceutical industry[R]. Geneva: International Federation of Pharmaceutical Manufacturers & Associations, 2024.
[5]
Ernst & Young. 2011 performance analysis of the global medical technology industry[R]. London: Ernst & Young,2012.
[6]
6Wresearch. Global biologics market (2026-2032)[R/OL].(2025-04)[2026-06-24]. https://www.6wresearch.com/industry-report/global-biologics-market.
[7]
Precedence Research. Medical devices market size envisioned at USD 996.93 billion by 2032[R/OL].(2023-12-04)[2026-06-24]. https://www.precedenceresearch.com/insights/medical-devices-market.
[8]
Frost & Sullivan. 全球生物药市场展望[R]. 上海: 弗若斯特沙利文咨询公司, 2023.
[9]
Evaluate MedTech. Global medical devices market outlook 2025[R]. London: Evaluate Ltd, 2025.
[10]
薛静文. 未来五年,我国医药工业发展方向已明[EB/OL].(2025-12-08)[2026-06-24]. https://www.cnpharm.com/c/2025-12-08/1086218.shtml.
[11]
中国医药企业管理协会. 2025年医药工业经济运行情况[R]. 北京: 中国医药企业管理协会, 2026.
[12]
中国医药统计网. 2015年1-12月份分行业生产情况[EB/OL].(2016-02-03)[2026-06-24]. https://www.yytj.org.cn/article.aspx?id=481.
[13]
Citeline. 2025 pharmaceutical R&D annual review[R]. New York: Citeline,2025.
[14]
清华大学药品监管科学研究院,医药魔方. 全球视野下的中国创新药产业:十年回顾与展望[R]. 北京: 清华大学, 2025.

Footnotes

利益冲突 所有作者声明无利益冲突

PDF(804 KB)

Accesses

Citation

Detail

Sections
Recommended

/